Corteva, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Charles Magro
- Full Time Employees
- 21,500
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- Address
- 9330 Zionsville Road Indianapolis IN United States of America 46268
- IPO Date
- May 24, 2019
- CIK
- 0001755672
- Website
- corteva.com
- Similar Companies
- Business
- Corteva, Inc. Corteva, Inc. (CTVA) develops and supplies advanced seed and crop protection products to enhance agricultural productivity worldwide. The company operates through two primary segments, Seed and Crop Protection; the Seed segment offers high-performance hybrid and traited seeds for row crops such as corn and soybeans under brands including Pioneer and Brevant, alongside specialty seeds for fruits, vegetables, and other crops, supported by digital selection tools and biotechnology traits for insect resistance and herbicide tolerance; the Crop Protection segment provides herbicides including the Enlist system, insecticides, fungicides, nitrogen stabilizers, seed treatments, biologicals, and pasture management solutions to combat weeds, diseases, insects, and nematodes. Corteva serves farmers and the agricultural input industry across more than 140 countries, with a focus on integrated solutions that combine genetics, chemistry, and digital agriculture technologies; it maintains a global manufacturing footprint, robust research and development investment exceeding $1.3 billion annually in genomics, biotechnology, and new active ingredients, and key brands like Pioneer, founded in 1926. Headquartered in Indianapolis, Indiana since 2022 after relocating from Delaware, the company employs over 20,000 people and traces its origins to the 2019 spin-off from DowDuPont as a pure-play agriscience entity. Recent developments include the announcement in late September 2025 of plans to separate into two independent public companies along seed and crop protection lines, with current CEO Chuck Magro to lead the crop protection spin-co; additionally, Corteva entered a strategic collaboration and joint venture with gene-editing firm Pairwise in 2024, investing $25 million in equity to advance climate-resilient crops, and reaffirmed its Delaware presence in October 2025 by relocating corporate offices to downtown Wilmington while retaining over 200 jobs.
Company News
Bank of New York Mellon Corp Acquires New Stake in Corteva, Inc. $CTVA
Advisors Capital Management LLC Takes Position in Corteva, Inc. $CTVA
Allworth Financial LP Buys New Stake in Corteva, Inc. $CTVA
Corteva Announces Early Tender Results and Extension of Expiration Date in Private Exchange Offers and Consent Solicitations for EIDP's 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033
Bell & Brown Wealth Advisors LLC Acquires Shares of 14,533 Corteva, Inc. $CTVA
DOLE vs. CTVA: Which Stock Is the Better Value Option?
Corteva's Higher 2026 Guidance Puts Investor Focus on Growth Drivers
Corteva Growth Improves, But Valuation Limits Upside
Corteva Announces Private Exchange Offers and Consent Solicitations for EIDP's 2.300% Senior Notes Due 2030, 5.125% Senior Notes Due 2032 and 4.800% Senior Notes Due 2033
Corteva Split Still Pending: Own The Preferreds
Corteva, Inc. (CTVA) Q2 2026 Earnings Call Transcript
Corteva Inc (CTVA) (Q2 2026) Earnings Call Highlights: Strong First-Half Performance and Raised Guidance Amid Market Challenges
Corteva Q2 Earnings Call Highlights
Are You Looking for a Top Momentum Pick? Why Corteva, Inc. (CTVA) is a Great Choice
Corteva Q2 Earnings Beat Estimates, Sales Miss, '26 Outlook Raised
Corteva: Strong Fundamentals, Limited Upside
Corteva, Inc. (CTVA) Reports Q2 Earnings: What Key Metrics Have to Say
Corteva, Inc. (CTVA) Q2 Earnings Beat Estimates
Corteva Delivers Strong 1H 2026, Raises FY 2026 Outlook, On-Track for October 1 Separation
Is CTVA Stock Worth Buying After a Powerful Rally and Earnings Beat?